Johanna (Hanneke) W.
- Country
- The Netherlands
- Department
- Medical Oncology
Research Overview
- Phase III Study of Rilvegostomig plus Combination Chemotherapy versus Durvalumab plus Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer
- A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX versus mFOLFIRINOX Alone in Patients with Resected Pancreatic Ductal Adenocarcinoma
- Phase 3 Randomized, Double-Blind Study of Pembrolizumab with Gemcitabine/Cisplatin vs. Placebo with Gemcitabine/Cisplatin in Advanced Biliary Tract Carcinoma
Data & Insights
Has run more than one trial at 82 of 190 partner sites.
Specializations
Pancreatic Cancer Research
The investigator specializes in treating complex pancreatic ductal adenocarcinoma and borderline resectable pancreatic cancer. Their work encompasses innovative therapeutic approaches including neoadjuvant treatments and advanced surgical interventions.
- Metastatic PDAC Management
- Combined Therapy Approaches
- Neoadjuvant Treatment Protocols
Biliary Tract Oncology
Expertise in treating cholangiocarcinoma and gallbladder carcinoma, with particular focus on both advanced and early-stage disease management. The investigator works with targeted therapies and traditional treatment approaches.
- Advanced Cholangiocarcinoma Treatment
- Post-Resection Care
- Targeted Therapeutic Approaches
Gastrointestinal Oncology
Focuses on treating complex gastrointestinal tract cancers and neuroendocrine tumors. The investigator's expertise extends to molecular-targeted treatments and innovative therapeutic strategies.
- GEP-NET Treatment
- MTAP-deletion Cancers
- Advanced GI Cancer Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.